Bardet-Biedl syndrome 4

Networked: 6 relevant articles (0 outcomes, 0 trials/studies)

1.	Schizophrenia (Dementia Praecox)
2.	Orofaciodigital Syndromes (Orofaciodigital Syndrome)
3.	Atrophy

Drugs and Important Biological Agents (IBA) related to Bardet-Biedl syndrome 4:

1.	Proteins (Proteins, Gene)FDA Link 01/01/2011 - "A novel missense mutation in Bardet-Biedl syndrome 4 protein (BBS4) was identified in a consanguineous family from Saudi Arabia. " 05/01/2014 - "Here, we show that loss of cilopathy-associated proteins Bardet-Biedl syndrome 4 (BBS4) or oral-facial-digital syndrome 1 (OFD1) results in the accumulation of signaling mediators normally targeted for proteasomal degradation. " 06/01/2010 - "PCM1 protein has been shown to interact directly with the disrupted-in-schizophrenia 1 (DISC1) protein, Bardet-Biedl syndrome 4, and Huntingtin-associated protein 1, and is important in neuronal cell growth. " 09/01/2008 - "To show that pericentriolar material 1 protein (PCM1) forms a complex at the centrosome with disrupted-in-schizophrenia 1 (DISC1) and Bardet-Biedl syndrome 4 protein (BBS4), which provides a crucial pathway for cortical development associated with the pathology of SZ. "
2.	Retinaldehyde (Retinal)IBA 01/01/2017 - "A Coding Variant in the Gene Bardet-Biedl Syndrome 4 (BBS4) Is Associated with a Novel Form of Canine Progressive Retinal Atrophy."
3.	Peptides (Polypeptides)IBA 09/11/2007 - "Although the overall photoreceptor polarity is not affected, this phenotype is accompanied by a misdistribution of the Bardet-Biedl syndrome 4 polypeptide and a decreased photoreceptor survival. "